| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $32,491,606 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 001 | 4 | NIH | 3/10/2026 | $32,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 000 | 4 | NIH | 1/29/2026 | $288,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 4 | NIH | 1/8/2026 | $468,449 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM150459 | Dynamic regulatory impact of human transposable elements on gene expression | 000 | 4 | NIH | 5/27/2026 | $387,465 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184781 | Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection | 000 | 2 | NIH | 6/26/2026 | $463,698 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03NS144710 | Development of a Mouse Model to Investigate the Role of ZBP1 in Neuroinflammation | 001 | 1 | NIH | 6/11/2026 | $1,500 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03NS144710 | Development of a Mouse Model to Investigate the Role of ZBP1 in Neuroinflammation | 000 | 1 | NIH | 6/9/2026 | $160,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 4 | NIH | 4/28/2026 | $541,883 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30AG085974 | Mechanisms of trans-synaptic pathological tau spreading in the human brain | 000 | 3 | NIH | 7/31/2026 | $49,430 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 001 | 3 | NIH | 8/10/2026 | $3,000,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 001 | 3 | NIH | 8/10/2026 | $262,299 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 001 | 3 | NIH | 8/10/2026 | $1,232,469 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060221 | Frustration effects on drug taking | 000 | 3 | NIH | 4/8/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034376 | CXCR3-Mediated Cell-Cell Communication in Glaucoma | 000 | 5 | NIH | 8/11/2026 | $430,917 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES033682 | Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action | 000 | 5 | NIH | 6/16/2026 | $356,219 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 001 | 4 | NIH | 3/20/2026 | $43,180 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 000 | 4 | NIH | 12/9/2025 | $388,626 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 001 | 4 | FDA | 3/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U24FD007821 | An Educational Program to Enhance Data Quality and Integrity for Regulated Studies Supporting the Advancement of Medical Countermeasures for High Consequence Pathogens | 000 | 4 | FDA | 1/28/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AG075254 | Sex Differences in Pain and Treatment and their Association with Alzheimer’s Disease and Related Dementias | 000 | 5 | NIH | 6/23/2026 | $123,750 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12AR084228 | UTMB Women's Health Research Scholars Program | 001 | 23 | NIH | 6/18/2026 | $619,041 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12AR084228 | UTMB Women's Health Research Scholars Program | 001 | 23 | NIH | 6/18/2026 | $250,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI189278 | Assembly of B. pseudomallei proteins to virus-like particles as a vaccine platform against melioidosis | 000 | 1 | NIH | 7/6/2026 | $200,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG097537 | Microglia and Tau Oligomer Polymorphs Interplay in Cognitive Resilience in Alzheimers disease | 001 | 1 | NIH | 3/4/2026 | $15,375 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG097537 | Microglia and Tau Oligomer Polymorphs Interplay in Cognitive Resilience in Alzheimers disease | 000 | 1 | NIH | 12/23/2025 | $548,723 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01ES037276 | Understanding the role of gut microbiome in trichloroethene-mediated autoimmunity | 000 | 1 | NIH | 3/31/2026 | $718,775 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30DA065327 | Mechanisms of prenatal opioid exposure on offspring brain development and behavior | 001 | 1 | NIH | 3/25/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30DA065327 | Mechanisms of prenatal opioid exposure on offspring brain development and behavior | 000 | 1 | NIH | 2/19/2026 | $39,039 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AG099446 | Characterizing Myeloid Nuclear Differentiation Antigen (MNDA) in Alzheimer's Disease | 001 | 1 | NIH | 6/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AG099446 | Characterizing Myeloid Nuclear Differentiation Antigen (MNDA) in Alzheimer's Disease | 000 | 1 | NIH | 6/16/2026 | $39,532 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH146681 | The role of defective pro-viruses and viral proteins in NeuroHIV and cure | 000 | 1 | NIH | 7/28/2026 | $448,120 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH146681 | The role of defective pro-viruses and viral proteins in NeuroHIV and cure | 000 | 1 | NIH | 7/28/2026 | $294,150 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI199805 | Role of long non-coding RNAs in modulating host immunity and pathogen survival during Orientia infection | 000 | 1 | NIH | 6/16/2026 | $444,125 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | RF1AG094765 | ApoE-Tau axis in preeclampsia, a severe pregnancy complication, and neurodegeneration | 000 | 1 | NIH | 5/19/2026 | $3,267,011 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AI199717 | Integrative metagenomics & metatranscriptomics features of enterohepatic recirculation in kidney transplant recipients | 000 | 1 | NIH | 5/19/2026 | $192,169 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03DE036061 | Modeling Causal Mediation by Dental Care and Risk Prediction of Jaw Osteonecrosis in Bisphosphonate Users | 000 | 1 | NIH | 7/10/2026 | $323,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease | 001 | 4 | NIH | 4/15/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG075725 | tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer’s Disease | 000 | 4 | NIH | 3/26/2026 | $783,306 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI197328 | Bacterial histamine production as a novel mechanism of host immune evasion | 001 | 1 | NIH | 4/13/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AI197328 | Bacterial histamine production as a novel mechanism of host immune evasion | 000 | 1 | NIH | 3/27/2026 | $42,009 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI195888 | Novel Artificial Intelligence approaches to distinguish allergenic from non-allergenic proteins | 000 | 1 | NIH | 2/13/2026 | $429,499 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077484 | Immunotherapy Targeting Tau Aggregate Polymorphs | 000 | 3 | NIH | 7/8/2026 | $617,502 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 001 | 10 | NIH | 6/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 000 | 10 | NIH | 3/24/2026 | $757,565 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 5 | NIH | 7/29/2026 | $198,400 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 5 | NIH | 7/29/2026 | $50,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 001 | 5 | NIH | 6/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077253 | The Role of Ubiquitination in Tau Oligomers Pathogenesis | 000 | 5 | NIH | 3/23/2026 | $748,330 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 4 | NIH | 2/6/2026 | $751,347 |
|
